BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1091185)

  • 1. Effect of prostaglandins F2 alpha and E2 on airway conductance in healthy subjects and asthmatic patients.
    Mathé AA; Hedqvist P
    Am Rev Respir Dis; 1975 Mar; 111(3):313-20. PubMed ID: 1091185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of inhaled prostaglandins E1, E2, and F2alpha on the airway resistance of healthy and asthmatic man.
    Smith AP; Cuthbert MF; Dunlop LS
    Clin Sci Mol Med; 1975 May; 48(5):421-30. PubMed ID: 1126133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchial hyperreactivity to prostaglandin F 2 and histamine in patients with asthma.
    Mathé AA; Hedqvist P; Holmgren A; Svanborg N
    Br Med J; 1973 Jan; 1(5847):193-6. PubMed ID: 4686554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men.
    Hardy CC; Robinson C; Tattersfield AE; Holgate ST
    N Engl J Med; 1984 Jul; 311(4):209-13. PubMed ID: 6588293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchodilator activity of aerosols of prostaglandins E1 and E2 in asthmatic subjects.
    Cuthbert MF
    Proc R Soc Med; 1971 Jan; 64(1):15-6. PubMed ID: 4927962
    [No Abstract]   [Full Text] [Related]  

  • 6. Atropine, sodium cromoglycate, and thymoxamine in PGF2 alpha-induced bronchoconstriction in extrinsic asthma.
    Patel KR
    Br Med J; 1975 May; 2(5967):360-2. PubMed ID: 124195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandins E2 and F2alpha reduce exhaled nitric oxide in normal and asthmatic subjects irrespective of airway caliber changes.
    Kharitonov SA; Sapienza MA; Barnes PJ; Chung KF
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1374-8. PubMed ID: 9817681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of sulphur dioxide induced bronchoconstriction in normal and asthmatic man.
    Snashall PD; Baldwin C
    Thorax; 1982 Feb; 37(2):118-23. PubMed ID: 6805088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, functional and pathogenetic aspects of bronchial reactivity to prostaglandins F2alpha, E1, and E2.
    Pasargiklian M; Bianco S; Allegra L
    Adv Prostaglandin Thromboxane Res; 1976; 1():461-75. PubMed ID: 136876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection.
    Empey DW; Laitinen LA; Jacobs L; Gold WM; Nadel JA
    Am Rev Respir Dis; 1976 Feb; 113(2):131-9. PubMed ID: 1247226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The response of normal and asthmatic subjects to prostaglandins E2 and F2alpha by different routes, and their significance in asthma.
    Smith AP; Cuthbert MF
    Adv Prostaglandin Thromboxane Res; 1976; 1():449-59. PubMed ID: 793362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of atropine on experimentally-induced airway obstruction in man.
    Eiser NM; Guz A
    Bull Eur Physiopathol Respir; 1982; 18(3):449-60. PubMed ID: 7074241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchial response to inhaled prostaglandin F2alpha in patients with common or aspirin-sensitive asthma.
    Orehek J; Gayrard P; Grimaud C; Charpin J
    J Allergy Clin Immunol; 1977 Jun; 59(6):414-9. PubMed ID: 864100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalance of endogenous prostanoids in moderate-to-severe asthma.
    Takemura M; Niimi A; Matsumoto H; Ueda T; Yamaguchi M; Matsuoka H; Jinnai M; Chung KF; Mishima M
    Allergol Int; 2017 Jan; 66(1):83-88. PubMed ID: 27424536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect on airways resistance of prostaglandin E1 given by aerosol to healthy and asthmatic volunteers.
    Cuthbert MF
    Br Med J; 1969 Dec; 4(5685):723-6. PubMed ID: 5354877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the bronchomotor effects of chemical mediators by prostaglandin F2 alpha in asthmatic subjects.
    Fish JE; Jameson LS; Albright A; Norman PS
    Am Rev Respir Dis; 1984 Oct; 130(4):571-4. PubMed ID: 6592997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of pharmacological antagonism produced by atropine in bronchi of normal and asthmatic subjects.
    Gillett MK; Snashall PD
    Eur Respir J; 1988 Jan; 1(1):27-33. PubMed ID: 3366235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise-related changes in plasma levels of 15-keto-13,14-dihydro-prostaglandin F2alpha and noradrenaline in asthmatic and normal subjects.
    Anderson SD; Pojer R; Smith ID; Temple D
    Scand J Respir Dis; 1976; 57(1):41-8. PubMed ID: 1273543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between response to inhaled prostaglandin E2 and chronic beta-adrenergic agonist treatment.
    Walters EH; Bevan M; Davies BH
    Thorax; 1982 Jun; 37(6):430-7. PubMed ID: 7135277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchopulmonary responses to prostaglandin F2alpha, histamine and acetylcholine in the dog.
    Wasserman MA
    Eur J Pharmacol; 1975; 32(02):146-55. PubMed ID: 1149802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.